2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2212):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-135200
    4-Amino benzamidoxime
    		99.89%
    4-Amino benzamidoxime (4-Amino-N'-hydroxybenzenecarboximidamide) is a synthetic intermediate useful for pharmaceutical synthesis.
    4-Amino benzamidoxime
  • HY-79602R
    p-Toluenesulfonamide (Standard)
    p-Toluenesulfonamide (Standard) is the analytical standard of p-Toluenesulfonamide (HY-79602). This product is intended for research and analytical applications. p-Toluenesulfonamide is an intermediate and plasticizer. p-Toluenesulfonamide is also the main degradation product of the disinfectant Chloramine-T (HY-B0959) in water. p-Toluenesulfonamide facilitates the localization of fluorescent probes to the endoplasmic reticulum.
    p-Toluenesulfonamide (Standard)
  • HY-W073260
    Lenvatinib impurity 1
    Lenvatinib impurity 1 is an impurity of Lenvatinib (HY-10981).
    Lenvatinib impurity 1
  • HY-Z0732
    Rotigotine impurity 1
    Rotigotine impurity 1 is an impurity of Rotigotine (HY-75502).
    Rotigotine impurity 1
  • HY-Z6409
    Palbociclib impurity 1
    		98.41%
    Palbociclib impurity 46 is an impurity of Palbociclib (HY-50767).
    Palbociclib impurity 1
  • HY-44009
    Lidocaine impurity 1
    Lidocaine impurity 1 is an impurity of Lidocaine (HY-B0185).
    Lidocaine impurity 1
  • HY-Z4726
    Linagliptin impurity 11
    Linagliptin impurity 11 (Linagliptin impurity YYJ) is an impurity of Linagliptin (HY-10284).
    Linagliptin impurity 11
  • HY-42223
    (1R,3S)-3-Amino-cyclopentanol
    (1R,3S)-3-Amino-cyclopentanol is a synthetic intermediate useful for pharmaceutical synthesis.
    (1R,3S)-3-Amino-cyclopentanol
  • HY-Z4758
    Edoxaban impurity 8
    Edoxaban Impurity 8 is an impurity of Edoxaban (HY-10264).
    Edoxaban impurity 8
  • HY-401505
    TD1092 intermediate-1
    TD1092 intermediate-1 is the intermediate of TD1092 (HY-151966). TD1092 intermediate-1 is an ADC-related molecule.
    TD1092 intermediate-1
  • HY-W100681R
    2'-Hydroxy-5'-methylacetophenone (Standard)
    Tetrahydropiperine (Standard) is the analytical standard of Tetrahydropiperine. This product is intended for research and analytical applications. Tetrahydropiperine, a cyclohexyl analogue of piperine, is the first natural aryl pentanamide from Piper longum. Tetrahydropiperine (compound 14) inhibits the cytochrome P450 (CYP) isoform CYP1A1/arylhydrocarbon hydroxylase (AHH; IC50=23 µM).
    2'-Hydroxy-5'-methylacetophenone (Standard)
  • HY-Z7471
    Cefmetazole impurity 1
    Cefmetazole impurity 1 is an impurity of Cefmetazole (HY-B1595).
    Cefmetazole impurity 1
  • HY-Z6417
    Dacomitinib impurity 12
    Dacomitinib impurity 12 is an impurity of Dacomitinib (HY-13272).
    Dacomitinib impurity 12
  • HY-169659
    8-Methyl-4-oxo-N,N-dipropyl-4H-thieno[3,2-c]chromene-2-carboxamide
    8-Methyl-4-oxo-N,N-dipropyl-4H-thieno[3,2-c]chromene-2-carboxamide is the drug intermediate for synthesis of pyruvate kinase inhibitor.
    8-Methyl-4-oxo-N,N-dipropyl-4H-thieno[3,2-c]chromene-2-carboxamide
  • HY-Z0750
    (S)-1-(3-Chloro-4-methylphenyl)ethan-1-amine hydrochloride
    (S)-1-(3-Chloro-4-methylphenyl)ethan-1-amine hydrochloride is a drug impurity.
    (S)-1-(3-Chloro-4-methylphenyl)ethan-1-amine hydrochloride
  • HY-130784
    Dihydro montelukast
    Dihydro montelukast (Impurity-3) is an impurity found during the synthesis of Montelukast sodium (HY-13315).
    Dihydro montelukast
  • HY-Z1494
    Brexpiprazole impurity 1
    Brexpiprazole impurity 1 is an impurity of Brexpiprazole (HY-15780).
    Brexpiprazole impurity 1
  • HY-Z6416
    Dacomitinib impurity 13
    Dacomitinib impurity 13 is an impurity of Dacomitinib (HY-13272).
    Dacomitinib impurity 13
  • HY-I0542
    Canagliflozin impurity 10
    Canagliflozin impurity 10 is an impurity of Canagliflozin (HY-10451).
    Canagliflozin impurity 10
  • HY-I0104
    Fesoterodine impurity 1
    Fesoterodine impurity 1 is an impurity of Fesoterodine (HY-70053).
    Fesoterodine impurity 1